Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Early recognition and aggressive treatment can significantly improve rare ANA-negative lupus with heart and skin issues.

Discoid Lupus Erythematosus often causes scarring hair loss, is influenced by genetics and environment, and requires early treatment to prevent worsening.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Early diagnosis and treatment of myositis in SLE patients lead to better outcomes.

Ongoing research and innovation are crucial for improving skin care and treatment.

Children with celiac disease often have skin issues, best managed with a gluten-free diet and sometimes medication.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Early detection and skin biopsies are crucial for treating skin cancer and diagnosing various skin conditions.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Finasteride helped treat a 28-year-old's facial skin condition.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Tph cells are linked to the severity of systemic lupus erythematosus.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Digital gangrene can be an initial symptom of late-onset systemic lupus erythematosus.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.